Labs / ADME, DMPK & toxicology
Araris Biotech
Wädenswil, Switzerland · ararisbiotech.com
Araris Biotech AG develops antibody-drug conjugate (ADC) linker technology and ADC candidates. It works on off-the-shelf antibody conjugation for cancer therapies and has programs including ARC-02 and ARC-401.
They take quote requests by email.
What they offer
ADC linker technology development
Develops a proprietary peptide linker platform for site-specific payload attachment to antibodies in one step.
ADC candidate design
Designs homogenous, stable, highly soluble ADCs using its linker technology.
One-step ADC conjugation
Generates ADCs from off-the-shelf antibodies without re-engineering or reducing the antibody.
What they work on
- Modalities
- Antibody, ADC, Peptide
- Therapeutic areas
- cancer, lymphomas, solid tumors
- Address
- Riedhofstrasse 11 , CH-8804 , Au ZH , Switzerland How to get to us info
Similar labs. Aurigene Pharmaceutical Services, Glykos, Sai Life, Veloxity Labs
Found in a contract services directory. Listing built from ararisbiotech.com. Work here? Claim this listing.